Cell Therapy Bioprocessing Market Geographic Analysis by 2028 The cell therapy bioprocessing market is one of the fastest growing sectors in the broader biopharmaceutical industry. Cell therapy is the application of living cells to treat medical conditions, and the bioprocessing aspect relates to the manufacture and production of these cell-based therapies. The cell therapy bioprocessing is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.5% from 2021-2028. Geographic Expansion: Because of the R&D and manufacturing capabilities of research and development centers in North America, Europe, and Asia, the cell therapy bioprocessing market expands in these respective regions. https://www.theinsightpartners.com/assets/rd-new-images/by_geography/cell-therapy-bioprocessing-market-global-geography.webp The cell therapy bioprocessing market is expected to continue its high growth in the coming years on account of high demand for customized and targeted treatments, the establishment of advanced technologies in bioprocessing, and the regulatory backing for the industrialization of treatments based on cell therapy.